Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”
This article is from
The Cancer Letter
archive.
Vol. 24 No. 42 | November 6, 1998
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Conferees Stalled On Money Bill, Running Out Of Time
September 17, 1976
TCL Archive
NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.
June 22, 2007
TCL Archive
NCI-Approved Group, Center Clinical Trials Listed
May 25, 2007
TCL Archive
NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit
November 18, 1994
TCL Archive
Patients on Hypertension Meds Lived Longer, Analysis Shows
January 31, 2014
TCL Archive
Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk
August 20, 1982